Cited by 3,559Angiogenesis and VEGF in CancerCancer Cells and MetastasisMathematical Biology Tumor Growth

The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.

Tumorigenesis and the angiogenic switch

Bergers, Gabriele, Benjamin, Laura E.·2003·Nature reviews. Cancer

Open this paper in CoChat — free account

Abstract

It has become evident that we cannot understand tumour growth without considering components of the stromal microenvironment, such as the vasculature. At the same time, the tumour phenotype determines the nature of the tumour vasculature. Much research is now devoted to determining the impact of angiogenesis on tumour development and progression, and the reciprocal influences of tumour products on the microvasculature. A more detailed understanding of the complex parameters that govern the interactions between the tumour and vascular compartments will help to improve anti-angiogenic strategies-- not only for cancer treatment, but also for preventing recurrence.

Integrity signals

Registry

Crossref · 10.1038/nrc1093

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis
Watnick, R. S., Cheng, Y.-N., Rangarajan, A., Ince, T. A., & Weinberg, R. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00030-8 · Cited by 318
Retracted
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,704
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,235
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699

Flagged first, then by citations

Show all 110 references

Research works printed but not linked: 2

Folkman, J. in Cancer Medicine (Holland, M.D. et al.) 2546 (BC Decker, Hamilton, Ontario, 2000).
Sternlicht, M. D. et al. Matrix proteinases as emerging targets in anticancer therapy: status and prospects. ETT 4, 609–633 (2000).

Sorted by citations

Items 401–500 of 1,010

Hypoxic induction of human visfatin gene is directly mediated by hypoxia‐inducible factor‐1
Bae, S., Kim, S.-R., Kim, J. G., Kim, J. Y., Koo, T. H., Jang, H., Yun, I., Yoo, M., & Bae, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.06.052 · Cited by 125
Tumor angiogenesis and novel antiangiogenic strategies
Gordon, M. S., Mendelson, D. S., & Kato, G. (2009) · International Journal of Cancer · doi:10.1002/ijc.25026 · Cited by 124
Zebrafish xenograft models of cancer and metastasis for drug discovery
Brown, H. K., Schiavone, K., Tazzyman, S. J., Heymann, D., & Chico, T. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1297416 · Cited by 130
Regulated Angiogenesis and Vascular Regression in Mice Overexpressing Vascular Endothelial Growth Factor in Airways
Bałuk, P., Lee, C. G., Link, H., Ator, E., Haskell, A., Elias, J. A., & McDonald, D. M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63369-x · Cited by 125
Pericytes, Mesenchymal Stem Cells and the Wound Healing Process
Mills, S. J., Cowin, A. J., & Kaur, P. (2013) · Cells · doi:10.3390/cells2030621 · Cited by 125
αvβ3‐ or α5β1‐Integrin‐Selective Peptidomimetics for Surface Coating
Mas‐Moruno, C., Fraioli, R., Rechenmacher, F., Neubauer, S., Kapp, T. G., & Kessler, H. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201509782 · Cited by 127
Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression
zhao, J., Zhang, Z., Xue, Y., Wang, G., Cheng, Y. G., Pan, Y., Zhao, S., & Hou, Y. (2018) · Theranostics · doi:10.7150/thno.29746 · Cited by 124
“It is well known that the spread and growth of tumor cells is dependent on the formation of new blood vessels and thus on angiogenesis [58].”
Background
Cancer metastasis: Molecular mechanisms and clinical perspectives
Khan, S. U., Fatima, K., Malik, F. A., Kalkavan, H., & Wani, A. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108522 · Cited by 127
Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effector function of CD8 + T cells
Kwon, H., Jeon, W. K., Hwang, J., Lee, C., So, J., Park, J., Ko, B., & Im, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.015 · Cited by 123
The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma
Numnum, T. M., Rocconi, R. P., Whitworth, J. M., & Barnes, M. N. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.05.018 · Cited by 123
Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer
Krämer, I., & Lipp, H. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00800.x · Cited by 125
Tumstatin, the NC1 domain of α3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth
Hamano, Y., & Kalluri, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.130 · Cited by 125
Extracellular Matrix Remodeling and Stiffening Modulate Tumor Phenotype and Treatment Response
Leight, J. L., Drain, A. P., & Weaver, V. M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-034431 · Cited by 131
“Contrary to normal blood vessels, those found in tumors are leaky, and they form dense, tortuous networks (Bergers & Benjamin 2003).”
Background
Peptide-Functionalized Phase-Transformation Nanoparticles for Low Intensity Focused Ultrasound-Assisted Tumor Imaging and Therapy
Zhu, L., Zhao, H., Zhou, Z., Xia, Y., Wang, Z., Ran, H., Li, P., & Ren, J. (2018) · Nano Letters · doi:10.1021/acs.nanolett.7b05087 · Cited by 122
Monoclonal antibody mechanisms of action in cancer
Weiner, G. J. (2007) · Immunologic Research · doi:10.1007/s12026-007-0073-4 · Cited by 122
Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model
Mathieu, V., Nève, N. D., Mercier, M. L., Dewelle, J., Gaussin, J., Dehoux, M., Robert Kiss, A., & Lefranc, F. (2008) · Neoplasia · doi:10.1593/neo.08928 · Cited by 124
The Tumor Microenvironment: Characterization, Redox Considerations, and Novel Approaches for Reactive Oxygen Species-Targeted Gene Therapy
Policastro, L. L., Ibañez, I. L., Notcovich, C., Duran, H. A., & Podhajcer, O. L. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4367 · Cited by 120
Recent advances in targeted nanoparticles drug delivery to melanoma
Li, J., Wang, Y., Liang, R., An, X., Wang, K., Shen, G., Tu, Y., Zhu, J., & Tao, J. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.11.006 · Cited by 125
Akt–Girdin Signaling in Cancer-Associated Fibroblasts Contributes to Tumor Progression
Yamamura, Y., Asai, N., Enomoto, A., Kato, T., Mii, S., Kondo, Y., Ushida, K., Niimi, K., Tsunoda, N., Nagino, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1317 · Cited by 121
Snail Promotes CXCR2 LigandDependent Tumor Progression in NonSmall Cell Lung Carcinoma
Yanagawa, J., Walser, T. C., Zhu, L. X., Hong, L., Fishbein, M. C., Mah, V. H., Chia, D., Goodglick, L., Elashoff, D. A., Luo, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1558 · Cited by 119
Current applications of antibody microarrays
Chen, Z., Dodig‐Crnković, T., Schwenk, J. M., & Tao, S. (2018) · Clinical Proteomics · doi:10.1186/s12014-018-9184-2 · Cited by 124
The role of neutrophils in cancer
Grecian, R., Whyte, M. K. B., & Walmsley, S. R. (2018) · British Medical Bulletin · doi:10.1093/bmb/ldy029 · Cited by 127
ROS: A “booster” for chronic inflammation and tumor metastasis
Chen, A., Huang, H., Fang, S., & Hang, Q. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189175 · Cited by 127
Magnesium and neoplasia: From carcinogenesis to tumor growth and progression or treatment
Wolf, F. I., Maier, J. A. M., Nasulewicz‐Goldeman, A., Feillet‐Coudray, C., Simonacci, M., Mazur, A., & Cittadini, A. R. M. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.02.016 · Cited by 121
CD47 Signaling Regulates the Immunosuppressive Activity of VEGF in T Cells
Kaur, S., Chang, T., SINGH, S. P., Lim, L., Mannan, P., Garfield, S. H., Pendrak, M. L., Soto‐Pantoja, D. R., Rosenberg, A. Z., Jin, S., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303116 · Cited by 126
Anti-angiogenic therapies for metastatic colorectal cancer
Wagner, D., Arnold, D., Grothey, A. A., Haerting, J., & Unverzagt, S. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005392.pub3 · Cited by 119
A Novel Xenograft Model in Zebrafish for High-Resolution Investigating Dynamics of Neovascularization in Tumors
Zhao, C., Wang, X., Zhao, Y., Li, Z., Lin, S., Wei, Y., & Yang, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021768 · Cited by 123
Trial Watch
Vacchelli, E., Galluzzi, L., Eggermont, A. M. M., Galon, J., Tartour, É., Zitvogel, L., & Kroemer, G. (2012) · OncoImmunology · doi:10.4161/onci.20459 · Cited by 122
Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response
Geindreau, M., Ghiringhelli, F., & Bruchard, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094871 · Cited by 126
“anti-angiogenic factors in favor of pro-angiogenic factors, mainly induced by hypoxia [5].”
BackgroundInfluential
Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2‐mediated PI3K/Akt/mTOR signaling pathway
He, L., Wu, Y., Lin, L., Wang, J., Wu, Y., Chen, Y., Yi, Z., Liu, M., & Pang, X. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01778.x · Cited by 119
The Role of Selected Chemokines and Their Receptors in the Development of Gliomas
Groblewska, M., Litman‐Zawadzka, A., & Mroczko, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103704 · Cited by 121
Notch signaling in the regulation of tumor angiogenesis
Rehman, A. O., & Wang, C. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.04.003 · Cited by 118
The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression
Akiyama, S., Furukawa, T., Sumizawa, T., Takebayashi, Y., Nakajima, Y., Shimaoka, S., & Haraguchi, M. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02193.x · Cited by 117
Transforming growth factor-beta signaling and tumor angiogenesis
Pardali, E. (2009) · Frontiers in bioscience · doi:10.2741/3573 · Cited by 117
Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture
Trapp, V., Parmakhtiar, B., Papazian, V., Willmott, L. J., & Fruehauf, J. P. (2010) · Angiogenesis · doi:10.1007/s10456-010-9187-8 · Cited by 121
TYROSINE KINASE INHIBITORS AND THE DAWN OF MOLECULAR CANCER THERAPEUTICS
Tibes, R., Trent, J. C., & Kurzrock, R. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100124 · Cited by 117
GPR56 Regulates VEGF Production and Angiogenesis during Melanoma Progression
Yang, L., Chen, G., Mohanty, S., Scott, G., Fazal, F., Rahman, A., Begum, S., Hynes, R. O., & Xu, L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4543 · Cited by 116
Vascular endothelial growth factor: Therapeutic possibilities and challenges for the treatment of ischemia
Crafts, T. D., Jensen, A. R., Blocher-Smith, E. C., & Markel, T. A. (2014) · Cytokine · doi:10.1016/j.cyto.2014.08.005 · Cited by 115
The antitumor activity of naturally occurring chromones: A review
Duan, Y.-D., Jiang, Y., Guo, F.-X., Chen, L., Xu, L., Zhang, W., & Liu, B. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.04.012 · Cited by 116
Time-resolved optical mammography between 637 and 985 nm: clinical study on the detection and identification of breast lesions
Taroni, P., Torricelli, A. M., Spinelli, L., Pifferi, A., Arpaia, F., Danesini, G. M., & Cubeddu, R. (2005) · Physics in Medicine and Biology · doi:10.1088/0031-9155/50/11/003 · Cited by 116
Melatonin modulates the expression of VEGF and HIF‐1α induced by CoCl2 in cultured cancer cells
Dai, M., Cui, P., Yu, M., Han, J., Li, H., & Xiu, R. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00498.x · Cited by 116
Positron Emission Tomography Imaging of Cancer Biology: Current Status and Future Prospects
Chen, K., & Chen, X. S. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.11.005 · Cited by 115
CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy
de Nigris, F., Crudele, V., Giovane, A., Casamassimi, A., Giordano, A., Garbán, H., Cacciatore, F., Pentimalli, F., Márquez‐Garbán, D. C., Petrillo, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008256107 · Cited by 115
Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications
Tarnawski, A. S., & Jones, M. K. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0479-y · Cited by 117
Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice
Moghaddam, S. J., Barta, P., Mirabolfathinejad, S. G., Ammar-Aouchiche, Z., Garza, N., Vo, T. T., Newman, R. A., Aggarwal, B. B., Evans, C. M., Tuvim, M. J., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp229 · Cited by 115
The role of tumor-associated macrophages in tumor vascularization
Guo, C., Buranych, A., Sarkar, D., Fisher, P. B., & Wang, X. (2013) · Vascular Cell · doi:10.1186/2045-824x-5-20 · Cited by 118
Rho-Associated Coiled-Coil Kinase (ROCK) in Molecular Regulation of Angiogenesis
Liu, J., Wada, Y., Katsura, M., Tozawa, H., Erwin, N. A., Kapron, C. M., Bao, G., & Liu, J. (2018) · Theranostics · doi:10.7150/thno.30305 · Cited by 117
The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy
Dredge, K. S., Hammond, E., Davis, K., Li, C. P., Liu, L., Johnstone, K., Handley, P., Wimmer, N., Gonda, T. J., Gautam, A. M., et al. (2009) · Investigational New Drugs · doi:10.1007/s10637-009-9245-5 · Cited by 113
Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones
Guo, Y., Wang, S., Hoot, D. R., & Clinton, S. K. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.08.006 · Cited by 113
Antiangiogenic gene therapy of cancer: recent developments
Tandle, A. T., Blazer, D. G., & Libutti, S. K. (2004) · Journal of Translational Medicine · doi:10.1186/1479-5876-2-22 · Cited by 114
Id2 Mediates Tumor Initiation, Proliferation, and Angiogenesis in Rb Mutant Mice
Lasorella, A., Rothschild, G., Yokota, Y., Russell, R. G., & Iavarone, A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3563-3574.2005 · Cited by 111
Secretory microRNAs as biomarkers of cancer
Kai, K., Dittmar, R. L., & Sen, S. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.12.011 · Cited by 118
The Biology of HDAC in Cancer: The Nuclear and Epigenetic Components
Hagelkrüys, A., Sawicka, A., Rennmayr, M., & Seiser, C. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_2 · Cited by 114
hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor
Liu, N., Ding, D., Hao, W., Yang, F., Wu, X., Wang, M., Xu, X., Ju, Z., Liu, J., Song, Z., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw549 · Cited by 112
“Angiogenesis, the growth of new blood vessels from preexisting vessels, is a vital process in development, wound healing, inflammation and tumorigenesis (24,26,28,36).”
Background
Angiogenesis and Multiple Myeloma
Giuliani, N., Storti, P., Bolzoni, M., Palma, B. D., & Bonomini, S. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0072-9 · Cited by 111
Variations in Surgical Procedures for Hind Limb Ischaemia Mouse Models Result in differences in Collateral Formation
Hellingman, A. A., Bastiaansen, A. J. N. M., de Vries, M. R., Seghers, L., Lijkwan, M. A., Löwik, C. W. G. M., Hamming, J. F., & Quax, P. H. A. (2010) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2010.07.009 · Cited by 111
Mechanisms Regulating Tumor Angiogenesis by 12-Lipoxygenase in Prostate Cancer Cells
Nie, D., Krishnamoorthy, S., Jin, R., Tang, K., Chen, Y., Qiao, Y., Zacharek, A., Guo, Y., Milanini, J., Pagès, G., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601887200 · Cited by 112
Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice
Zhao, M., Tang, S., Marsh, J. L., Shankar, S., & Srivastava, R. K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.009 · Cited by 111
Growing tumor vessels: More than one way to skin a cat – Implications for angiogenesis targeted cancer therapies
de Oliveira, R. L., Hamm, A., & Mazzone, M. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.04.001 · Cited by 115
Combined trastuzumab and paclitaxel treatment better inhibits ErbB‐2‐mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone
Klos, K. S., Zhou, X., Lee, S., Zhang, L., Yang, W., Nagata, Y., & Yu, D. (2003) · Cancer · doi:10.1002/cncr.11656 · Cited by 111
Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm
Taroni, P., Danesini, G. M., Torricelli, A. M., Pifferi, A., Spinelli, L., & Cubeddu, R. (2004) · Journal of Biomedical Optics · doi:10.1117/1.1695561 · Cited by 110
ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis
Romagnoli, M., Mineva, N. D., Polmear, M. M., Conrad, C., Srinivasan, S. S., Loussouarn, D., Barillé‐Nion, S., Georgakoudi, I., Dagg, Á., McDermott, E. W. M., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201303373 · Cited by 112
“…in the tumorigenesis process, solid tumors stop increasing in mass (tumor dormancy) unless they can overcome hypoxic stress by stimulating angiogenesis, which provides oxygen and nutrients essential for further tumor growth (Bergers & Benjamin, 2003; Naumov et al , 2006; Majmundar et al , 2010).”
Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells
Wu, M. H., Huang, C.-Y., Lin, J. A., Wang, S.-W., Peng, C.-Y., Cheng, H.-C., & Tang, C. H. (2013) · Oncogene · doi:10.1038/onc.2013.109 · Cited by 109
Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
Wang, J., Li, G., Wang, Y., Tang, S., Sun, X., Feng, X., Li, Y., Bao, G., Li, P., Mao, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6373 · Cited by 114
Lactic acidosis switches cancer cells from aerobic glycolysis back to dominant oxidative phosphorylation
Wu, H., Ying, M., & Hu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9746 · Cited by 114
Plasmalemmal Vesicle Associated Protein-1 (PV-1) is a marker of blood-brain barrier disruption in rodent models
Shue, E. H., Carson-Walter, E. B., Liu, Y., Winans, B., Ali, Z. S., Chen, J., & Walter, K. A. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-29 · Cited by 109
Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78
Katanasaka, Y., Ishii, T., Asai, T., Naitou, H., Maeda, N., Koizumi, F., Miyagawa, S., Ohashi, N., & Oku, N. (2010) · International Journal of Cancer · doi:10.1002/ijc.25276 · Cited by 110
Antiangiogenic Therapy with Mammalian Target of Rapamycin Inhibitor RAD001 (Everolimus) Increases Radiosensitivity in Solid Cancer
Manegold, P. C., Paringer, C., Kulka, U., Krimmel, K., Eichhorn, M., Wilkowski, R., Jauch, K., Guba, M. O., & Bruns, C. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0955 · Cited by 109
Corrigendum to “New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy”
Guo, Q., Jin, Z., Yuan, Y., Liu, R., Xu, T., Wei, H., Xu, X., He, S., Chen, S., Shi, Z., et al. (2018) · Journal of Immunology Research · doi:10.1155/2018/6728474 · Cited by 108
Targeted Delivery of Antisense Inhibitor of miRNA for Antiangiogenesis Therapy Using cRGD-Functionalized Nanoparticles
Liu, X., Song, W., Sun, T., Zhang, P., & Wang, J. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100315q · Cited by 109
Microvesicles as Mediators of Intercellular Communication in Cancer
Antonyak, M. A., & Cerione, R. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0856-1_11 · Cited by 113
Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis
Albig, A. R., Roy, T. G., Becenti, D. J., & Schiemann, W. P. (2007) · Angiogenesis · doi:10.1007/s10456-007-9075-z · Cited by 108
Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo
Shi, P., Aluri, S. R., Lin, Y., Shah, M. S., Edman, M. C., Dhandhukia, J. P., Cui, H., & MacKay, J. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.013 · Cited by 107
Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells
Yamamoto, K., Ohga, N., Hida, Y., Maishi, N., Kawamoto, T., Kitayama, K., Akiyama, K., Osawa, T., Kondoh, M., Matsuda, K., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.59 · Cited by 108
Impact of isoflurane on malignant capability of ovarian cancer in vitro
Luo, X., Zhao, H., Hennah, L., Ning, J., Liu, J., Tu, H., & Ma, D. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu408 · Cited by 107
The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
Azad, T., Ghahremani, M., & Yang, X. (2019) · Cells · doi:10.3390/cells8050407 · Cited by 111
Cancer stem cells: the lessons from pre‐cancerous stem cells
Gao, J. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00170.x · Cited by 106
Melatonin suppresses tumor progression by reducing angiogenesis stimulated by HIF ‐1 in a mouse tumor model
Kim, K., Choi, J., Kang, I., Kim, K., Jeong, C., & Jeong, J. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01030.x · Cited by 106
Targeting neuropilin-1 in human leukemia and lymphoma
Karjalainen, K., Jaalouk, D. E., Bueso-Ramos, C., Zurita, A. J., Kuniyasu, A., Eckhardt, B. L., Marini, F. C., Lichtiger, B., O'Brien, S. M., Kantarjian, H. M., et al. (2010) · Blood · doi:10.1182/blood-2010-05-282921 · Cited by 106
Embedded Spheroids as Models of the Cancer Microenvironment
Tevis, K. M., Colson, Y. L., & Grinstaff, M. W. (2017) · Advanced Biosystems · doi:10.1002/adbi.201700083 · Cited by 109
Role of tumor-derived exosomes in cancer metastasis
Wee, I. J. Y., Syn, N. L. X., Sethi, G., Goh, B. C., & Wang, L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.10.004 · Cited by 107
The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer
García-Hernández, L., García‐Ortega, M. B., Ruiz-Alcalá, G., Carrillo, E., Marchal, J. A., & García, M. Á. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010370 · Cited by 111
Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells
Garcia, V. A., González, A., Alonso‐González, C., Martínez‐Campa, C., & Cos, S. (2012) · Journal of Pineal Research · doi:10.1111/jpi.12007 · Cited by 106
Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis
Palma, M. D., & Naldini, L. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.003 · Cited by 106
Enhanced Expression of Asparagine Synthetase under Glucose-Deprived Conditions Protects Pancreatic Cancer Cells from Apoptosis Induced by Glucose Deprivation and Cisplatin
Cui, H., Darmanin, S., Natsuizaka, M., Kondo, T., Asaka, M., Shindoh, M., Higashino, F., Hamuro, J., Okada, F., Kobayashi, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2519 · Cited by 106
Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer
Winder, T., & Lenz, H. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.005 · Cited by 113
Surfactant-based drug delivery systems for treating drug-resistant lung cancer
Kaur, P., Garg, T., Rath, G., Murthy, R. S. R., & Goyal, A. K. (2014) · Drug Delivery · doi:10.3109/10717544.2014.935530 · Cited by 106
Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence
Goradel, N. H., Asghari, M. H., Moloudizargari, M., Negahdari, B., Haghi‐Aminjan, H., & Abdollahi, M. R. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.09.022 · Cited by 105
Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies
Liu, X., Zhang, J., Yi, T., Li, H., Tang, X., Liu, D., Wu, D., & Li, Y. (2025) · Biomarker Research · doi:10.1186/s40364-025-00779-x · Cited by 125
“Tumor angiogenesis is a complex process regulated by pro-angiogenic and anti-angiogenic factors within solid tumors [28, 29].”
Identification of mRNAs that continue to associate with polysomes during hypoxia
Thomas, J. D., & Johannes, G. J. (2007) · RNA · doi:10.1261/rna.534807 · Cited by 114
Phospholipase Cε promotes intestinal tumorigenesis of Apc Min/+ mice through augmentation of inflammation and angiogenesis
Li, M., Edamatsu, H., Kitazawa, R., Kitazawa, S., & Kataoka, T. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp125 · Cited by 103
Carbon quantum dots: A promising nanocarrier for bioimaging and drug delivery in cancer
Jana, P., & Dev, A. (2022) · Materials Today Communications · doi:10.1016/j.mtcomm.2022.104068 · Cited by 106
The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?
Jurj, A. M., Ionescu, C., Berindan‐Neagoe, I., & Braicu, C. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02484-1 · Cited by 113
“Meanwhile, in tumor tissues, these cells are leaky and are able to form a denser network [244].”
Background
Targeting the Expression of Platelet-Derived Growth Factor Receptor by Reactive Stroma Inhibits Growth and Metastasis of Human Colon Carcinoma
Kitadai, Y., Sasaki, T., Kuwai, T., Nakamura, T., Bucana, C. D., & Fidler, I. J. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060653 · Cited by 104
Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade
Takumi, K., Fukukura, Y., Higashi, M., Ideue, J., Umanodan, T., Hakamada, H., Kanetsuki, I., & Yoshiura, T. (2015) · European Journal of Radiology · doi:10.1016/j.ejrad.2015.05.005 · Cited by 103
Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms
Chia, W. K., Ali, R., & Toh, H. C. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.137 · Cited by 102
Enzyme catalysis powered micro/nanomotors for biomedical applications
Mathesh, M., Sun, J., & Wilson, D. A. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01245a · Cited by 104
The Anti-Angiogenic Effect of Sinomenine
Kok, T.-W., Yue, P. Y. K., Mak, N. K., Fan, T., Liu, L., & Wong, R. N. (2005) · Angiogenesis · doi:10.1007/s10456-005-2892-z · Cited by 103
Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
Pastorino, F., Paolo, D. D., Piccardi, F., Nico, B., Ribatti, D., Daga, A., Baio, G., Neumaier, C. E., Brignole, C., Loi, M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0804 · Cited by 102
Impact of tumor microenvironment on oncolytic viral therapy
Wojton, J., & Kaur, B. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.02.014 · Cited by 103

Authors: Bergers, G., & Benjamin, L. E.
Affiliations: University of California, San Francisco (US)
Beth Israel Deaconess Medical Center (US)
Corresponding author: Bergers, Gabriele
ORCID: Bergers, Gabriele
Venue: Nature reviews. Cancer
Publisher: Springer Science and Business Media LLC
Published: 2003-06
Volume: 3
Issue: 6
Pages: 401-410
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1093
OpenAlex: W2804842145
Cited by: 3,559
References: 110
Citations by year: 2026: 53 · 2025: 79 · 2024: 123 · 2023: 122 · 2022: 142 · 2021: 160 · 2020: 149 · 2019: 159 · 2018: 162 · 2017: 176 · 2016: 148 · 2015: 176 · 2014: 232 · 2013: 223 · 2012: 198
FWCI: 9.49
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
Keywords: carcinogenesis, angiogenic switch, tumor angiogenesis, tumor vasculature, tumor microenvironment, tumor-stroma interactions, tumor progression, anti-angiogenic therapy, tumor recurrence
MeSH terms: Animals, Humans, Neoplasms, Neovascularization, Pathologic, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumorigenesis and the angiogenic switch

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks